Neoplasia/BPH

	Urine-based PSMA detection for noninvasive prostate cancer diagnosis: recent advances, translational challenges, and future perspectives. Front Oncol Jiao Z, Deng C, Hu J, Zhu S. PMID: 42137166 [PubMed]
	Distinct protein and metabolic profiles in patients with advanced clear-cell renal cell carcinoma treated with sunitinib: a study of the Spanish oncology genitourinary group. Front Oncol Quintás G, Sanmartín E, Garcia-Gimenez A, Muñoz-Langa J, Collado A, Suárez C, García Del Muro X, Méndez-Vidal MJ, García-Sánchez J, Salvador-Coloma C, Laínez N, Gallardo E, Munárriz J, Vázquez S, Molins C, Font de Mora J, Reynés G. PMID: 42137158 [PubMed]
	Diagnostic utility of Ki-67 proliferation index, PSA, and other immunohistochemical markers in prostatic basal cell carcinoma: A review of 24 cases in the current literature and discussion on current treatment and diagnostics. Rare Tumors DeBinya L, Mathesh V, Wang J. PMID: 42136983 [PubMed]
	The evolving role of PSA in prostate cancer screening: revisiting the evidence in the era of personalized medicine. Adv Lab Med Filella X. PMID: 42136976 [PubMed]
	Disitamab vedotin (RC48) combined with PD-1 inhibitors in locally advanced or metastatic urothelial carcinoma: clinical outcomes and prognostic factors from a multicenter real-world study. Front Immunol Zou XC, Xu LY, Yuan YY, Zhang GY, Huang JB, Zeng T. PMID: 42136642 [PubMed - indexed for MEDLINE]
	MRI Diagnosis of Giant Renal Hamartoma With Renal Venous Tumor Thrombus: Report of One Case and Literature Review. Zhongguo Yi Xue Ke Xue Yuan Xue Bao Cen WH, Shen J, Xia SS, Li YK, Yang H, Ban Y. PMID: 42136348 [PubMed - indexed for MEDLINE]
	Impact of Hormonal and Radiation Therapy on Bladder Outlet Obstruction in High-Risk Localized Prostate Cancer: A Prospective Pressure-Flow Study. Int J Urol Kyoda Y, Hori M, Nakanishi M, Shindo T, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. PMID: 42136062 [PubMed - indexed for MEDLINE]
	Letter to the Editor: Advanced and Metastatic Prostate Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment, and Follow-up. Eur Urol De Laere B, Mortezavi A, Eklund M, Grönberg H, ProBio Investigators. PMID: 42135176 [PubMed - as supplied by publisher]
	Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer Meirson T, Mutti L, Goldstein DA, Barkan T, Mutai R, Markel G, Goldman A, Cosmai L, Rizzo M, Porta C. PMID: 42135107 [PubMed - as supplied by publisher]
	Osteoporosis knowledge, health beliefs, and self-efficacy in UK men with prostate cancer: a cross-sectional primary care survey. Br J Gen Pract Huang Q, Oliver P, Evans J, Brown J, Mitchell C. PMID: 42134941 [PubMed - indexed for MEDLINE]
	Prostate-specific antigen (PSA) test for prostate cancer screening. Cochrane Database Syst Rev Franco JV, Hwang EC, Jung JH, Vaimberg O, Ilic D, Cleves A, Dahm P. PMID: 42134821 [PubMed - indexed for MEDLINE]
	Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional non-inferiority phase 3 trial (PCS-XI, NCT05820633). Radiother Oncol Fabi F, Crook J, Jolicoeur M, Rauth S, Koll W, Tisseveransinghe S, Ebacher A, Niazi T, Duplan D, Bernard AA, Vavassis P, Foster W, Vigneault É, Archambault L, Beaulieu L, Lavallée MC, Lacroix F, Carignan D, Martin AG. PMID: 42134662 [PubMed - as supplied by publisher]
	NCCN GuidelinesÂ® Insights: Prostate Cancer, Version 5.2026. J Natl Compr Canc Netw Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, Chapin B, Cheng HH, Cho SY, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Ippolito JE, Karnes RJ, Kishan AU, Kuettel MR, Lang JM, Lee D, Lotan T, McDonald A, Morgan TM, Pessoa R, Rais-Bahrami S, Roach M 3rd, Robin T, Rosenfeld S, Scarpato KR, Seibert T, Shabsigh A, Szmulewitz R, Teply BA, Tward J, Valicenti R, VanderWeele D, Wong JK, Kovach E, Freedman-Cass D. PMID: 42134408 [PubMed - indexed for MEDLINE]
	Perioperative Systemic Treatment Options for Muscle-Invasive Bladder Cancer. J Natl Compr Canc Netw Brown JR, Parikh M. PMID: 42134402 [PubMed - indexed for MEDLINE]
	How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer. Am Soc Clin Oncol Educ Book Richardson N, Tewari AK, Giannatempo P, Basin MF, Nuzzo A, Mascaro F, Feldman DR, Adra N, Daneshmand S. PMID: 42133890 [PubMed - indexed for MEDLINE]
	[Â¹â¸F]PSMA-1007 PET/CT in biochemical recurrence after radical prostatectomy: A single-center experience of detection rate and lesion distribution. PLoS One Wang Y, Feng L, He L, Liu N, Wang H. PMID: 42133652 [PubMed - indexed for MEDLINE]
	UBE2S emerges as a key driver in an NK cell-based prognostic model for clear cell renal cell carcinoma. PLoS One Leng K, Zhou Y, Zhao J, Wang X, Song H. PMID: 42133651 [PubMed - indexed for MEDLINE]
	Single-port EDGE SP1000 versus multi-port Da Vinci Xi robot-assisted radical prostatectomy: a comparative analysis of technique and perioperative outcomes. J Robot Surg Zhang J, Zhou L, Li H, Du H, Wang H, Tai S, Liang C. PMID: 42133277 [PubMed - indexed for MEDLINE]
	A Bioinspired Three-Dimensional High-Curvature Nano-Interface Integrated Microfluidic Chip for Small Extracellular Vesicles Enrichment and Machine Learning-Assisted Prostate Cancer Precision Diagnosis. Adv Sci (Weinh) Wang L, Liang Y, Sulaiman M, Du J, Jiang M, Wang Z, Yu X, Xu L. PMID: 42133268 [PubMed - as supplied by publisher]
	The role of extracellular vesicles-associated proteins markers in prostate cancer: a review. Discov Oncol Said DS, Abdullah MNH, Nurdin A. PMID: 42133214 [PubMed - as supplied by publisher]

Articles 1 - 20 / 187858

Page 1 of 9393



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy